GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Targeting head and neck cancer cells and the adverse tumor microenvironment with a novel small-molecule STAT3 inhibitor

$666,718
David John Tweardy · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Inflammation and the esophageal tumor microenvironment

$666,706
Anil K Rustgi · University Of Pennsylvania · U01 · FY2009 · CA

Gamma delta T cell based melanoma therapies

$666,701
Xiaowei Xu · University Of Pennsylvania · R01 · FY2022 · CA

Massive single cell proteomics for cancer biology

$666,640
Ljiljana Pasa-Tolic · Battelle Pacific Northwest Laboratories · R01 · FY2022 · CA

POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma

$666,466
Diane M Simeone · New York University School Of Medicine · R01 · FY2022 · CA

PPARD hyperactivation promotes pancreatic intraepithelial neoplasia progression into pancreatic ductal adenocarcinoma

$666,423
Imad Shureiqi · University Of Michigan At Ann Arbor · R01 · FY2024 · CA

Combination antigen sensing engineered T cell for precise recognition and enhanced elimination of solid tumors

$666,268
Kole T Roybal · University Of California, San Francisco · R01 · FY2025 · CA

Modulation of Epigenetic Target in the Bone to Treat Breast Cancer Metastasis

$666,169
Han Xiao · Rice University · R01 · FY2023 · CA

Virus host interactions in clinical samples

$666,119
Joseph Ziegelbauer · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Combination antigen sensing engineered T cell for precise recognition and enhanced elimination of solid tumors

$666,104
Kole T Roybal · University Of California, San Francisco · R01 · FY2023 · CA

Variation in tumor-associated immune profiles and colorectal cancer outcomes

$665,918
Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · CA

An urinary drug disposing approach for treatment of bladder Cancer

$665,916
Benedict Shek Hang Law · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer

$665,878
Leopoldo Nicolas Segal · New York University School Of Medicine · R37 · FY2021 · CA

Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma

$665,841
Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA

Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma

$665,839
Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA

Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma

$665,839
Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA

Differential Inflammasome Regulation in the pathogenesis of S. aureus osteomyelitis

$665,686
Deborah V Novack · Washington University · R01 · FY2025 · AI

Using artificial intelligence to discover spatial, genomic, and pathologic biomarkers to guide and augment immune checkpoint inhibitor therapy for gastric cancer

$665,617
Sam C. Wang · Ut Southwestern Medical Center · R01 · FY2025 · CA

Defining brain-body feedback loops mediating stress-induced metastasis

$665,155
Mikala Egeblad · Johns Hopkins University · U01 · FY2024 · CA

Biomarkers of Vision Loss in Children with Optic Pathway Gliomas

$665,112
Robert Andrew Avery · Children'S Hosp Of Philadelphia · R01 · FY2022 · EY

Developing a novel combination immunotherapy for triple-negative breast cancer

$664,874
Naoto T Ueno · University Of Hawaii At Manoa · R01 · FY2023 · CA

Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer

$664,854
Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · DE

Case GI SPORE

$664,839
Sanford D Markowitz · Case Western Reserve University · P50 · FY2022 · CA

Administrative Supplement to MD Anderson Cancer Center Prostate Cancer SPORE

$664,838
Christopher J. Logothetis · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA

The impact of interstitial fluid flow on CAR T cell trafficking, distribution, and efficacy

$664,834
Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · NS